Stenotrophomonas maltophilia Infections: Clinical Characteristics and Factors Associated with Mortality of Hospitalized Patients

References

• Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41.22232370
   PubMed Web of Science ®Google Scholar
• Looney WJ, Narita M, Muhlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis. 2009;9(5):312–323. doi:10.1016/S1473-3099(09)70083-019393961
   PubMed Web of Science ®Google Scholar
• Fihman V, Le Monnier A, Corvec S, et al. Stenotrophomonas maltophilia–the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study. J Infect. 2012;64(4):391–398. doi:10.1016/j.jinf.2012.01.00122245400
   PubMed Web of Science ®Google Scholar
• Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis. 2002;34(12):1653–1656. doi:10.1086/34070712032905
   PubMed Web of Science ®Google Scholar
• VanCouwenberghe CJ, Farver TB, Cohen SH. Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens. Infect Control Hosp Epidemiol. 1997;18(5):316–321. doi:10.2307/301412249154473
   PubMed Web of Science ®Google Scholar
• Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect. 2008;70(2):101–108. doi:10.1016/j.jhin.2008.05.02018621440
   PubMed Web of Science ®Google Scholar
• Rattanaumpawan P, Ussavasodhi P, Kiratisin P, Aswapokee N. Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria. BMC Infect Dis. 2013;13167.
   Web of Science ®Google Scholar
• Jeon YD, Jeong WY, Kim MH, et al. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia. Medicine (Baltimore). 2016;95(31):e4375. doi:10.1097/MD.000000000000437527495046
   PubMed Web of Science ®Google Scholar
• Xun M, Zhang Y, Li BL, Wu M, Zong Y, Yin YM. Clinical characteristics and risk factors of infections caused by Stenotrophomonas maltophilia in a hospital in northwest China. J Infect Dev Ctries. 2014;8(8):1000–1005. doi:10.3855/jidc.423625116665
   PubMed Web of Science ®Google Scholar
• Sanchez MB, Hernandez A, Martinez JL. Stenotrophomonas maltophilia drug resistance. Future Microbiol. 2009;4(6):655–660. doi:10.2217/fmb.09.4519659422
   PubMed Web of Science ®Google Scholar
• Vila J, Marco F. Interpretative reading of the non-fermenting gram-negative bacilli antibiogram. Enferm Infecc Microbiol Clin. 2002;20(6):304–310. doi:10.1016/S0213-005X(02)72803-612084355
   PubMed Web of Science ®Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332. doi:10.1016/j.ajic.2008.03.00218538699
   PubMed Web of Science ®Google Scholar
• Saugel B, Eschermann K, Hoffmann R, et al. Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients. Eur J Clin Microbiol Infect Dis. 2012;31(7):1419–1428. doi:10.1007/s10096-011-1459-822057419
   PubMed Web of Science ®Google Scholar
• Garazi M, Singer C, Tai J, Ginocchio CC. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review. J Hosp Infect. 2012;81(2):114–118. doi:10.1016/j.jhin.2012.02.00822494851
   PubMed Web of Science ®Google Scholar
• Samonis G, Karageorgopoulos DE, Maraki S, et al. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One. 2012;7(5):e37375. doi:10.1371/journal.pone.003737522624022
   PubMed Web of Science ®Google Scholar
• Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. Eur J Clin Microbiol Infect Dis. 2007;26(1):13–20. doi:10.1007/s10096-006-0243-717200840
   PubMed Web of Science ®Google Scholar
• Del Toro MD, Rodriguez-Bano J, Herrero M, et al. Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study. Medicine (Baltimore). 2002;81(3):228–239. doi:10.1097/00005792-200205000-0000611997719
   PubMed Web of Science ®Google Scholar
• Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev. 1998;11(1):57–80.9457429
   PubMed Web of Science ®Google Scholar
• Hanes SD, Demirkan K, Tolley E, et al. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis. 2002;35(3):228–235. doi:10.1086/34102212115086
   PubMed Web of Science ®Google Scholar
• Muder RR, Harris AP, Muller S, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis. 1996;22(3):508–512. doi:10.1093/clinids/22.3.5088852971
   PubMed Web of Science ®Google Scholar
• Lai CH, Chi CY, Chen HP, et al. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect. 2004;37(6):350–358.15599467
   PubMedGoogle Scholar
• Wang WS, Liu CP, Lee CM, Huang FY. Stenotrophomonas maltophilia bacteremia in adults: four years’ experience in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2004;37(6):359–365.15599468
   PubMedGoogle Scholar
• Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW. Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J Infect. 2002;45(1):47–53. doi:10.1053/jinf.2002.097812217732
   PubMed Web of Science ®Google Scholar
• Kwa AL, Low JG, Lim TP, Leow PC, Kurup A, Tam VH. Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures. Ann Acad Med Singapore. 2008;37(10):826–830.19037515
   PubMed Web of Science ®Google Scholar
• Chang LL, Lin HH, Chang CY, Lu PL. Increased incidence of class 1 integrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother. 2007;59(5):1038–1039. doi:10.1093/jac/dkm03417329265
   PubMed Web of Science ®Google Scholar
• Ko JH, Kang CI, Cornejo-Juárez P, et al. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. Clin Microbiol Infect. 2019;25(5):546–554. doi:10.1016/j.cmi.2018.11.00830448331
   PubMed Web of Science ®Google Scholar
• Wang YL, Scipione MR, Dubrovskaya Y, Papadopoulos J. Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. Antimicrob Agents Chemother. 2014;58(1):176–182. doi:10.1128/AAC.01324-1324145530
   PubMed Web of Science ®Google Scholar
• Kim EJ, Kim YC, Ahn JY, et al. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains. BMC Infect Dis. 2019;19(1):754. doi:10.1186/s12879-019-4394-431462215
   PubMed Web of Science ®Google Scholar
• Sumida K, Chong Y, Miyake N, et al. Risk factors associated with Stenotrophomonas maltophilia bacteremia: a matched case-control study. PLoS One. 2015;10(7):e0133731. doi:10.1371/journal.pone.013373126208218
   PubMed Web of Science ®Google Scholar